The oncogenic role of PILRB is proved in gastric tumorigenesis, providing new insights into the regulation of PI3K/AKT signaling in GC and establishing PILRB as a biomarker for simvastatin therapy resistance in GC. This evidence concerns the gene PILRB and gastric cancer.